id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-M-2634-0002,FDA,FDA-2015-M-2634,Medical Devices: Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Approval,2015-11-18T05:00:00Z,2015,11,2015-11-18T05:00:00Z,,2024-11-07T23:33:14Z,2015-29450,1,0,0900006481d56a5d
FDA-2015-M-2634-0001,FDA,FDA-2015-M-2634,"Premarket Approval Response from FDA CDRH to Calderma Laboratories, L.P., Restylane Lyft with Lidocaine",Other,Approval,2015-09-16T04:00:00Z,2015,9,2015-09-16T04:00:00Z,,2015-09-16T16:48:23Z,,0,0,0900006481c7990f